XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balances at Dec. 31, 2023 $ 93,462 $ (93,051) $ 411
Balance, shares at Dec. 31, 2023 1,833,877      
Issuance of common stock upon exercise of warrants,  net of issuance costs 3,635 3,635
Issuance of common stock upon exercise of warrants, net of issuance costs, shares 897,393      
Issuance of warrants to consultants for services 6 6
Stock-based compensation expense 293 293
Net loss (3,763) (3,763)
Balances at Mar. 31, 2024 97,396 (96,814) 582
Balance, shares at Mar. 31, 2024 2,731,270      
Balances at Dec. 31, 2023 93,462 (93,051) 411
Balance, shares at Dec. 31, 2023 1,833,877      
Net loss       (8,309)
Balances at Sep. 30, 2024 109,025 (101,360) 7,665
Balance, shares at Sep. 30, 2024 4,765,300      
Balances at Mar. 31, 2024 97,396 (96,814) 582
Balance, shares at Mar. 31, 2024 2,731,270      
Issuance of common stock upon exercise of warrants,  net of issuance costs
Issuance of common stock upon exercise of warrants, net of issuance costs, shares 496,000      
Issuance of warrants to consultants for services 11 11
Stock-based compensation expense 270 270
Net loss (1,930) (1,930)
Issuance of common stock and warrants in private placement, net of issuance costs 7,400 7,400
Issuance of common stock and warrants in private placement, net of issuance costs, shares 169,498      
Issuance of common stock to consultants for services   14   14
Issuance of common stock to consultants for services, shares 4,720      
Balances at Jun. 30, 2024 105,091 (98,744) 6,347
Balance, shares at Jun. 30, 2024 3,401,488      
Issuance of warrants to consultants for services 6 6
Stock-based compensation expense 142 142
Net loss (2,616) (2,616)
Issuance of common stock and warrants in private placement, net of issuance costs 3,786 3,786
Issuance of common stock and warrants in private placement, net of issuance costs, shares 1,363,812      
Balances at Sep. 30, 2024 109,025 (101,360) 7,665
Balance, shares at Sep. 30, 2024 4,765,300      
Balances at Dec. 31, 2024 112,141 (104,187) 7,954
Balance, shares at Dec. 31, 2024 5,889,520      
Stock-based compensation expense 317 317
Net loss (3,864) (3,864)
Balances at Mar. 31, 2025 112,458 (108,051) 4,407
Balance, shares at Mar. 31, 2025 5,889,520      
Balances at Dec. 31, 2024 112,141 (104,187) 7,954
Balance, shares at Dec. 31, 2024 5,889,520      
Net loss       (14,276)
Balances at Sep. 30, 2025 $ 1 120,995 (118,464) 2,532
Balance, shares at Sep. 30, 2025 8,266,877      
Balances at Mar. 31, 2025 112,458 (108,051) 4,407
Balance, shares at Mar. 31, 2025 5,889,520      
Stock-based compensation expense 242 242
Net loss (5,013) (5,013)
Issuance of common stock and warrants in private placement, net of issuance costs 3,642 3,642
Issuance of common stock and warrants in private placement, net of issuance costs, shares 828,000      
Common stock consideration for acquisition 1,305 1,305
Common stock consideration for acquisition, shares 607,287      
Balances at Jun. 30, 2025 117,647 (113,064) 4,583
Balance, shares at Jun. 30, 2025 7,324,807      
Issuance of common stock upon exercise of warrants,  net of issuance costs 866   866
Issuance of common stock upon exercise of warrants, net of issuance costs, shares 180,000      
Stock-based compensation expense 55 55
Net loss (5,400) (5,400)
Issuance of common stock under At-The-Market program, net of issuance costs $ 1 2,427 2,428
Issuance of common stock under At-The-Market program, net of issuance costs, shares 762,070      
Balances at Sep. 30, 2025 $ 1 $ 120,995 $ (118,464) $ 2,532
Balance, shares at Sep. 30, 2025 8,266,877